Effect of the COVID-19 Pandemic on the Psychological Health of Patients Who Underwent Liver Transplantation Due to Hepatocellular Carcinoma

dc.authoridCOLAK, Cemil/0000-0001-5406-098X
dc.authoridBAGCI, NAZLICAN/0000-0001-8914-5465
dc.authoridSAHIN, TEVFIK TOLGA/0000-0002-9132-6115
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridKUCUKAKCALI, ZEYNEP/0000-0001-7956-9272
dc.authoridTamer, Murat/0000-0001-9142-1844
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridBOZKIR, CIGDEM/0000-0002-1103-6290
dc.contributor.authorAkbulut, Sami
dc.contributor.authorKucukakcali, Zeynep
dc.contributor.authorSaritas, Hasan
dc.contributor.authorBozkir, Cigdem
dc.contributor.authorTamer, Murat
dc.contributor.authorAkyuz, Musap
dc.contributor.authorBagci, Nazlican
dc.date.accessioned2024-12-24T19:33:33Z
dc.date.available2024-12-24T19:33:33Z
dc.date.issued2023
dc.departmentSiirt Üniversitesi
dc.description.abstractBackground: The primary aim of this study was to compare liver transplant (LT) recipients with and without hepatocellular carcinoma (HCC) in terms of COVID-19-related depression, anxiety, and stress. Method: A total of 504 LT recipients with (HCC group; n = 252) and without HCC (non-HCC group; n = 252) were included in the present case-control study. Depression Anxiety Stress Scales (DASS-21) and Coronavirus Anxiety Scale (CAS) were used to evaluate the depression, stress, and anxiety levels of LT patients. DASS-21 total and CAS-SF scores were determined as the primary outcomes of the study. Poisson regression and negative binomial regression models were used to predict the DASS and CAS scores. The incidence rate ratio (IRR) was used as a coefficient. Both groups were also compared in terms of awareness of the COVID-19 vaccine. Results: Poisson regression and negative binomial regression analyses for DASS-21 total and CAS-SF scales showed that the negative binomial regression method was the appropriate model for both scales. According to this model, it was determined that the following independent variables increased the DASS-21 total score: non-HCC (IRR: 1.26; p = 0.031), female gender (IRR: 1.29; p = 0.036), presence of chronic disease (IRR: 1.65; p < 0.001), exposure to COVID-19 (IRR: 1.63; p < 0.001), and nonvaccination (IRR: 1.50; p = 0.002). On the other hand, it was determined that the following independent variables increased the CAS score: female gender (IRR:1.75; p = 0.014) and exposure to COVID-19 (IRR: 1.51; p = 0.048). Significant differences were found between the HCC and non-HCC groups in terms of median DASS-21 total (p < 0.001) and CAS-SF (p = 0.002) scores. Cronbach's alpha internal consistency coefficients of DASS-21 total and CAS-SF scales were calculated to be 0.823 and 0.783, respectively. Conclusion: This study showed that the variables including patients without HCC, female gender, having a chronic disease, being exposed to COVID-19, and not being vaccinated against COVID-19 increased anxiety, depression, and stress. High internal consistency coefficients obtained from both scales indicate that these results are reliable.
dc.identifier.doi10.3390/diagnostics13081410
dc.identifier.issn2075-4418
dc.identifier.issue8
dc.identifier.pmid37189511
dc.identifier.scopus2-s2.0-85153769616
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.3390/diagnostics13081410
dc.identifier.urihttps://hdl.handle.net/20.500.12604/8199
dc.identifier.volume13
dc.identifier.wosWOS:000978004700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofDiagnostics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241222
dc.subjectliver transplantation
dc.subjecthepatocellular carcinoma
dc.subjectCOVID-19 pandemic
dc.subjectDepression Anxiety Stress Scale
dc.subjectCoronavirus Anxiety Scale
dc.subjectCOVID-19 vaccine
dc.subjectvaccine awareness
dc.titleEffect of the COVID-19 Pandemic on the Psychological Health of Patients Who Underwent Liver Transplantation Due to Hepatocellular Carcinoma
dc.typeArticle

Dosyalar